AIPTO

The startup develops a brain cancer therapy that utilizes AI to model the cellular and molecular pathology of patient tumors, including their complex microenvironments. This technology enables precise predictions of drug responses, allowing clinicians to tailor treatments for individual brain cancer patients.

Traction –/10

HQ unknown

210+ followers

Artificial Intelligence
Biotechnology
Healthcare Technology

Updated 5 months ago

Funding

Funding rounds are not available yet.

Founders

1 founder

Hui Wu

Founder of iCCAMT/Hexaell/Aipto Techbio

Product

Features

The startup develops a brain cancer therapy that utilizes AI to model the cellular and molecular pathology of patient tumors, including their complex microenvironments. This technology enables precise predictions of drug responses, allowing clinicians to tailor treatments for individual brain cancer patients.